Allergan, Inc. (Allergan) is a multi-specialty health care company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. The Company discovers, develops and commercializes specialty pharmaceutical, biologics, medical device and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in more than 100 countries globally. Its business model includes products for which patients may be eligible for reimbursement and cash pay products that consumers pay for directly. It sells its products directly through its own sales subsidiaries in 36 countries and additionally through independent distributors in over 100 countries globally. On January 15, 2010, the Company completed the acquisition of Serica Technologies, Inc.